Press Release

In mid-December, PT Ferron PAR PharmaCeuticals implement the National Working Meeting of Regional Leadership (RAKERNAS PIMDA), precisely on December 14 to 16 December 2009 which was held at the Theater Titan, Titan Building Center, Bintaro.

Major symposium was held on December 29 to 31 October 2009, which is located at Hotel Sanur Paradise Plaza, Bali.

In a separate place on October 11th 2009, also held symposiums  launch PS Neulin at the Titan Theater - Titan Center (Jakarta). In cooperation with PERDOSSI symposium entitled "The New Dawn in Managing Post Stroke Patients" featured three expert speakers are:

On October 10th, 2009 has been held Dinner Symposium with the title "The New Dawn in Managing Post Stroke Patients", which was attended by more than 600 participants consisting of nerve specialists, internists, and GP.

European markets, particularly the UK market is "highly regulated" which is very strict in terms of quality, so it is not easily penetrated by a local pharmaceutical player. Therefore, this event represents a new milestone not only for PT Ferron PAR Pharmaceuticals, but also for the pharmaceutical industry in Indonesia in general.

On March 13, 2008 PT Ferron PAR PharmaCeuticals received GMP certification from the UK-MHRA (United Kingdom Medicine and Healthcare Products Regulatory Agency). UK-MHRA is the agency responsible for monitoring safety, quality and effectiveness of drugs marketed in the UK (UK-United Kingdom).